With the combination of two excellent technology platforms.

Together, the platforms build a new approach to low-cost mass production of secure and efficient vaccines. ARTES’ business plan is to enhance its position as a preferred development partner for vaccine manufacturer.. ARTES acquires ANAVAX virus-like particle technology from Select Vaccines ARTES Biotechnology announces today the acquirement of the ANAVAX virus-like particle technology from Select Vaccines Ltd. ANAVAX is certainly a patent-protected VLP technology that can be used to the prevention of several infectious diseases.With the combination of two excellent technology platforms, ANAVAX and the Hansenula expression system, ARTES has positioned itself as a distinctive partner for the vaccine industry.It consequently accurately mimics the chewing movement and forces in human being jaws. It will soon be packed with copies of genuine human teeth to be able to check how implants, alternative or restored tooth might wear during use. Using nothing more sophisticated than an office projector, a digital camera and some customised software, Alemzadeh has adapted a cheap method of imaging 3D objects. The Dental care Optical Scanner, ‘Dento-OS’, as he calls it, will allow him to scan standard plaster casts of tooth created by dentists. The detailed 3D digital images that result will be used to machine replicas that’ll be loaded in to the jaw. The potential of Dento-Munch and Dento-OS to boost the examining of dental components was quickly recognised and the systems have been patented in america and the UK respectively.